tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

AXGN Stock Latest News

Axogen Reports Strong Q3 Growth and FDA Progress
Company AnnouncementsAxogen Reports Strong Q3 Growth and FDA Progress
2M ago
AXGN
Raymond James says AxoGen selloff ‘overdone,’ raises price target to $18
PremiumThe Fly
Raymond James says AxoGen selloff ‘overdone,’ raises price target to $18
2M ago
AXGN
AxoGen trading resumes
PremiumThe Fly
AxoGen trading resumes
2M ago
AXGN
AxoGen trading halted, volatility trading pause
PremiumThe Fly
AxoGen trading halted, volatility trading pause
2M ago
AXGN
AxoGen Reports Strong Q3 2024 Revenue Growth
PremiumCompany Announcements
AxoGen Reports Strong Q3 2024 Revenue Growth
2M ago
8K
AXGN
AxoGen reports Q3 adjusted EPS 7c, consensus 1c
PremiumThe FlyAxoGen reports Q3 adjusted EPS 7c, consensus 1c
2M ago
AXGN
AxoGen reiterates FY24 revenue view of $182M-$186M, consensus $184.72M
Premium
The Fly
AxoGen reiterates FY24 revenue view of $182M-$186M, consensus $184.72M
2M ago
AXGN
AXGN Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
AXGN Upcoming Earnings Report: What to Expect?
2M ago
AXGN
AxoGen Seeks Accelerated FDA Review for Avance Nerve Graft®
PremiumCompany Announcements
AxoGen Seeks Accelerated FDA Review for Avance Nerve Graft®
4M ago
8K
AXGN
AxoGen completes submission of BLA to U.S. FDA for Avance Nerve Graft
PremiumThe Fly
AxoGen completes submission of BLA to U.S. FDA for Avance Nerve Graft
4M ago
AXGN
AxoGen reports inducement grant under Nasdaq listing rule
PremiumThe Fly
AxoGen reports inducement grant under Nasdaq listing rule
4M ago
AXGN
AxoGen Appoints New CEO and Board Chair for Strategic Renewal
PremiumCompany Announcements
AxoGen Appoints New CEO and Board Chair for Strategic Renewal
5M ago
8K
AXGN
AxoGen price target raised to $17 from $15 at Canaccord
PremiumThe FlyAxoGen price target raised to $17 from $15 at Canaccord
5M ago
AXGN
AxoGen price target raised to $20 from $17 at JMP Securities
Premium
The Fly
AxoGen price target raised to $20 from $17 at JMP Securities
5M ago
AXGN
AxoGen appoint Dale as CEO, Thomas as Chairman
Premium
The Fly
AxoGen appoint Dale as CEO, Thomas as Chairman
5M ago
AXGN
AxoGen Updates Corporate Presentation for Stakeholders
PremiumCompany Announcements
AxoGen Updates Corporate Presentation for Stakeholders
5M ago
8K
AXGN
AxoGen sees FY24 revenue $182M-$186M, consensus $178.9M
PremiumThe Fly
AxoGen sees FY24 revenue $182M-$186M, consensus $178.9M
5M ago
AXGN
AxoGen reports Q2 adjusted EPS 5c, consensus (4c)
PremiumThe Fly
AxoGen reports Q2 adjusted EPS 5c, consensus (4c)
5M ago
AXGN
Is AXGN a Buy, Before Earnings?
PremiumPre-Earnings
Is AXGN a Buy, Before Earnings?
5M ago
AXGN
AxoGen reports inducement grants under Nasdaq listing rule
PremiumThe FlyAxoGen reports inducement grants under Nasdaq listing rule
6M ago
AXGN
AxoGen initiated with an Outperform at Raymond James
Premium
The Fly
AxoGen initiated with an Outperform at Raymond James
6M ago
AXGN
AxoGen announces full launch of Avive+ Soft Tissue Matrix
Premium
The Fly
AxoGen announces full launch of Avive+ Soft Tissue Matrix
6M ago
AXGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >